Hematology System

In November 2005, Cholestech signed a definitive agreement with Boule Diagnostic International (Boule), an international manufacturer of hematology systems, headquartered in Stockholm, Sweden. Under the terms of the agreement, Cholestech will collaborate with Boule on the development and commercialization of a point of care Complete Blood Count (CBC) system, designed for waiver under CLIA. Cholestech will receive exclusive distribution rights covering all human applications in the United States and Canada.